Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pomalidomide Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103787956B reveals efficient Pd/C hydrogenation for pomalidomide intermediates. High yield, mild conditions, scalable for pharmaceutical manufacturing supply chains.
Patent CN110724125A reveals a mild copper-catalyzed route for 3-(7-hydroxy-1-oxoisoindole-2-yl)piperidine-2,6-diketone, offering superior stability and cost reduction in API manufacturing.
Advanced synthesis of 3-aminopiperidine-2,6-dione hydrochloride via L-glutamic acid cyclization. Offers superior purity, reduced toxicity, and cost-effective scaling for pharmaceutical supply chains.